Anti-EGFL6 抗体
Anti-EGFL6 antibody
Be the first to review this product! Submit a review
|
(9 Publications)
Rabbit Polyclonal EGFL6 antibody. Suitable for WB, IHC-P, ICC/IF and reacts with Human samples. Cited in 9 publications. Immunogen corresponding to Recombinant Fragment Protein within Human EGFL6 aa 1-250.
查看别名
MAEG, PP648, UNQ281/PRO320, EGFL6, Epidermal growth factor-like protein 6, EGF-like protein 6, MAM and EGF domains-containing gene protein
- IHC-P
Unknown
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-EGFL6 antibody (AB140079)
Immunohistochemical analysis of formalin-fixed, paraffin-embedded, Human fetal liver tissue labelling EGFL6 with ab140079 at 1/100 dilution.
- WB
Unknown
Western blot - Anti-EGFL6 antibody (AB140079)
All lanes:
Western blot - Anti-EGFL6 antibody (ab140079) at 1/1000 dilution
All lanes:
Human fetal kidney lysate
Predicted band size: 61 kDa
false
反应性数据
性能和储存信息
形式
复溶
纯化工艺
存储溶液
运输条件
推荐的短期储存条件
推荐的长期储存条件
分装信息
储存信息
补充信息
This supplementary information is collated from multiple sources and compiled automatically.
Biological function summary
This protein influences cell proliferation and differentiation. EGFL6 is not a part of a larger protein complex but functions through its interactions with other cellular components. Its activity affects cell behavior which is especially noted during development and tissue regeneration processes. EGFL6 modulates the extracellular environment through binding to receptor tyrosine kinases mediating signaling that promotes cellular motility and survival.
Pathways
EGFL6 integrates into significant pathways such as the PI3K/AKT and MAPK signaling pathways. Through these pathways it maintains cellular processes related to growth and survival by interacting with proteins like AKT1 and MAPK1. These signaling cascades are fundamental in mediating responses to growth factors and adjusting cell fate decisions.
产品实验方案
- Visit the General protocols
- Visit the Troubleshooting
靶点信息
文献 (9)
Recent publications for all applications. Explore the full list and refine your search
In vivo (Athens, Greece) 38:2455-2463 PubMed39187367
2024
Applications
Unspecified application
Species
Unspecified reactive species
Clinical & experimental metastasis 40:357-371 PubMed37378837
2023
Applications
Unspecified application
Species
Unspecified reactive species
Theranostics 11:9738-9751 PubMed34815781
2021
Applications
Unspecified application
Species
Unspecified reactive species
Frontiers in oncology 10:1451 PubMed32983976
2020
Applications
Unspecified application
Species
Unspecified reactive species
Cell death & disease 11:345 PubMed32393810
2020
Applications
Unspecified application
Species
Unspecified reactive species
The Kaohsiung journal of medical sciences 35:550-558 PubMed31162822
2019
Applications
Unspecified application
Species
Unspecified reactive species
Molecular carcinogenesis 58:967-979 PubMed30693973
2019
Applications
Unspecified application
Species
Unspecified reactive species
Cancer medicine 7:6281-6289 PubMed30444069
2018
Applications
Unspecified application
Species
Unspecified reactive species
BMJ open 8:e021385 PubMed29934389
2018
Applications
Unspecified application
Species
Unspecified reactive species
Abcam Product Promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com